May 21, 2018May 21, 2018

Immuron’s IMM-124E Significantly Eases Symptoms of Chronic Colitis in Mouse Model, Company Reports

News

Immuron’s investigational therapy IMM-124E significantly reduced intestinal inflammation in mice models of chronic colitis, the company reports. These results add to previous preclinical evidence showing the therapy to also of benefit ... Read more

April 19, 2017

Immuron Announces Positive Results of IMM-124E in Acute Colitis Research Program

News

Australia’s Immuron announced beneficial results of IMM-124E in acute models of colitis, including clinical parameters, tissue analysis, and immunological biomarkers. Colitis refers mainly to ulcerative colitis and Crohn’s disease, major categories ... Read more